Q4 2024 Holdings
Filed 2025-02-13 | 40 holdings | $892.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Soleno Therapeutics Inc(SLNO) | Common | 834203309 | $282.8M | 6,291,851 | 31.7% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $106.1M | 2,283,975 | 11.9% |
| Geron Corp(GERN) | Common | 374163103 | $96.4M | 27,225,292 | 10.8% |
| Terns Pharmaceuticals Inc(TERN) | Common | 880881107 | $38.2M | 6,895,746 | 4.3% |
| Avadel Pharmaceuticals PLC | ADR | G29687103 | $28.2M | 2,684,109 | 3.2% |
| Dyne Therapeutics Inc(DYN) | Common | 26818M108 | $26.3M | 1,114,960 | 2.9% |
| Aclaris Therapeutics, Inc.(ACRS) | Common | 00461U105 | $22.0M | 8,888,888 | 2.5% |
| Delcath Systems, Inc.(DCTH) | Common | 24661P807 | $20.6M | 1,708,579 | 2.3% |
| Viridian Therapeutics Inc(VRDN) | Common | 92790C104 | $18.8M | 982,576 | 2.1% |
| Cidara Therapeutics, Inc.(CDTX) | Common | 171757206 | $18.0M | 670,600 | 2.0% |
| Erasca Inc(ERAS) | Common | 29479A108 | $17.0M | 6,756,756 | 1.9% |
| Trevi Therapeutics Inc(TRVI) | Common | 89532M101 | $14.4M | 3,487,903 | 1.6% |
| Astria Therapeutics Inc(CATBUSD) | Common | 04635X102 | $13.9M | 1,552,685 | 1.6% |
| Rezolute Inc(RZLT) | Common | 76200L309 | $13.7M | 2,797,704 | 1.5% |
| Sera Prognostics Inc(SERA) | Common | 81749D107 | $13.4M | 1,650,440 | 1.5% |
| Tourmaline Bio Inc.(TRML) | Common | 89157D105 | $12.0M | 591,882 | 1.3% |
| Corvus Pharmaceuticals Holdings(CRVS) | Common | 221015100 | $12.0M | 2,234,566 | 1.3% |
| Instil Bio Inc(TIL) | Common | 45783C200 | $11.2M | 585,485 | 1.3% |
| Oric Pharmaceuticals Inc(ORIC) | Common | 68622P109 | $10.3M | 1,277,818 | 1.2% |
| Abeona Therapeutics, Inc.(ABEO) | Common | 00289Y206 | $10.3M | 1,842,751 | 1.1% |
| Zenas Biopharma Inc(ZBIO) | Common | 98937L105 | $9.7M | 1,183,260 | 1.1% |
| Bright Minds Biosciences Inc(DRUG) | Common | 10919W405 | $9.1M | 251,572 | 1.0% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $8.8M | 1,505,862 | 1.0% |
| Cogent Biosciences Inc(COGT) | Common | 19240Q201 | $8.8M | 1,122,471 | 1.0% |
| Celcuity Inc(CELC) | Common | 15102K100 | $8.0M | 610,500 | 0.9% |
| Verastem Inc(VSTM) | Common | 92337C203 | $8.0M | 1,538,461 | 0.9% |
| Unicycive Therapeutics | Common | 90466Y103 | $7.9M | 9,970,152 | 0.9% |
| Regulus Therapeutics Inc(RGLS) | Common | 75915K309 | $7.9M | 5,000,000 | 0.9% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $7.6M | 1,105,454 | 0.9% |
| Compass Pathway PLC(CMPS) | SPONSORED ADS | 20451W101 | $6.1M | 1,608,000 | 0.7% |
| IO Biotech Inc(IOBT) | Common | 449778109 | $5.7M | 6,173,439 | 0.6% |
| Aligos Therapeutics Inc(ALGS) | Common | 01626L204 | $5.7M | 141,879 | 0.6% |
| Compass Therapeutics Inc(CMPX) | Common | 20454B104 | $5.2M | 3,556,023 | 0.6% |
| Allakos Inc(ALLKGUSD) | Common | 01671P100 | $3.6M | 2,956,110 | 0.4% |
| Corbus Pharmaceuticals Holdings(CRBP) | Common | 21833P301 | $2.0M | 166,794 | 0.2% |
| Bolt Therapeutics Inc(BOLT1EUR) | Common | 097702104 | $1.9M | 3,521,291 | 0.2% |
| Tenax Therapeutics Inc(TENX) | Common | 88032L605 | $1.3M | 208,333 | 0.1% |
| DBV Technologies SA(DBVT) | SPONSORED ADS | 23306J309 | $98.9K | 32,020 | 0.0% |
| Q32 Bio Inc.(QTTB) | Common | 746964105 | $70.7K | 20,559 | 0.0% |
| Precision Biosciences Inc(DTIL) | Common | 74019P207 | $17.8K | 4,675 | 0.0% |